Premium
FDA on CBD in pregnancy and breastfeeding
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
the brown university child and adolescent behavior letter
Language(s) - English
Resource type - Journals
eISSN - 1556-7575
pISSN - 1058-1073
DOI - 10.1002/cbl.30458
Subject(s) - cannabidiol , breastfeeding , food and drug administration , pregnancy , medicine , ingredient , cannabis , psychiatry , traditional medicine , obstetrics , pharmacology , pediatrics , pathology , biology , genetics
The Food and Drug Administration (FDA) has strongly advised against the use of cannabidiol (CBD) in any form during pregnancy or while breastfeeding. The same warning applies to tetrahydrocannabinol (THC), the psychoactive ingredient of marijuana, and marijuana. These warnings apply to the use of these substances in any form.